Erratum: Intra-individual randomised comparison of gadobutrol 1.0 M versus gadobenate dimeglumine 0.5 M in patients scheduled for preoperative breast MRI (European Radiology DOI: 10.1007/s00330-012-2557-4);Intra-individual randomised comparison of gadobutrol 1.0M versus gadobenate dimeglumine 0.5M in patients scheduled for preoperative breast MRI

European Radiology

Volumn 23, Issue 1, 2013, Pages 84-92

  Pediconi, F ^a,e   Kubik Huch, R ^b   Chilla, B ^b   Schwenke, C ^c   Kinkel, K ^d  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Cantonal Hospital Baden   (Switzerland)

^c SCO:SSiS   (Germany)

^d Clinique des Grangettes   (Switzerland)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Breast neoplasms; Comparative study; Gadobenate dimeglumine; Gadobutrol; Magnetic resonance imaging; Dimeglumine; Gadobenate

Indexed keywords

GADOBENATE DIMEGLUMINE; GADOBUTROL;

ADULT; ARTICLE; BREAST CANCER; BREAST EXAMINATION; CANCER DIAGNOSIS; CANCER STAGING; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG SAFETY; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY; UNSPECIFIED SIDE EFFECT;

EID: 84871298403     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-013-2908-9     Document Type: Erratum

References (16)

1. Mann RM, Kuhl CK, Kinkel K et al (2008) Breast MRI: guidelines from the European Society of Breast Imaging. Eur Radiol 18:1307-1318
2. Kuhl C (2007) The current status of breast MR imaging. Part I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice. Radiology 244:356-378 (Pubitemid 47080868)
3. Rohrer M, Bauer H, Mintorovitch J et al (2005) Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol 40:715-724 (Pubitemid 41546838)
4. Bellin M, Van Der Molen A (2008) Extracellular gadolinium-based contrast media: an overview. Eur J Radiol 66:160-167
5. Bayer Healthcare (2008) Gadovist summary of product characteristics. Bayer, Berkshire
6. Hammerstingl R, Adam G, Ayuso JR et al (2009) Comparison of 1.0M gadobutrol and 0.5M gadopentetate dimeglumine-enhanced magnetic resonance imaging in five hundred seventy-two patients with known or suspected liver lesions: results of a multicenter, double-blind, interindividual, randomized clinical phase-III trial. Invest Radiol 44:168-176
7. Pediconi F, Catalano C, Occhiato R et al (2005) Breast lesion detection and characterization at contrast-enhanced MR mammography: gadobenate dimeglumine versus gadopentetate dimeglumine. Radiology 237:45-56 (Pubitemid 41346145)
8. Pediconi F, Catalano C, Padula S et al (2008) Contrast-enhanced MR mammography: improved lesion detection and differentiation with gadobenate dimeglumine. AJR Am J Roentgenol 191:1339-1346
9. Martincich L, Faivre-Pierret M, Zechmann CM et al (2011) Multicenter, double-blind, randomized, intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for breast MR imaging (DETECT Trial). Radiology 258:396-408
10. Obuchowski NA (1998) On the comparison of correlated proportions for clustered data. Stat Med 17:1495-1507 (Pubitemid 28330346)
11. Schwenke C, Busse R (2007) Analysis of differences in proportions from clustered data with multiple measurements in diagnostic studies. Methods Inf Med 46:548-552 (Pubitemid 47598972)
12. El Khouli RH, Macura KJ, Jacobs MA et al (2009) Dynamic contrast-enhanced MRI of the breast: quantitative method for kinetic curve type assessment. AJR Am J Roentgenol 193:W295-W300
13. Ikeda DM, Hylton NM, Kinkel K et al (2001) Development, standardization, and testing of a lexicon for reporting contrast-enhanced breast magnetic resonance imaging studies. J Magn Reson Imaging 13:889-895 (Pubitemid 32479947)
14. Baltzer PA, Benndorf M, Dietzel M et al (2010) False-positive findings at contrast enhanced breast MRI: a BI-RADS descriptor study. AJR Am J Roentgenol 194:1658-1663
15. Thomassin-Naggara I, Trop I, Chopier J et al (2011) Nonmasslike enhancement at breast MR imaging: the added value of mammography and US for lesion categorization. Radiology 261:69-79, Epub 2011 Jul 19
16. Forsting G (2006) Gadovist 1.0M: tolerance and clinical safety. Neuroradiology 48:87